Resource details
Human skin fibroblasts, obtained by skin biopsy of a symptomatic, female 25-year-old spinocerebellar type 2 (SCA2) patient (anonymized as H266), were reprogrammed using episomal vectors carrying transcripts for human OCT4, SOX2, KLF4, L-MYC, LIN28, and small hairpin RNA for TP53 (Okita et al., 2011) . The clone described in this publication was termed H266 clone (c) 10. The absence of the reprogramming plasmids was confirmed by quantitative PCR (qPCR) on genomic DNA (Fig. 1A) .
SCA2 is a dominantly inherited neurodegenerative disorder caused by a mutation in the ATXN2 gene. Normal alleles contain 22 CAG repeats with CAA interruptions (also coding for glutamine), whereas disease causing alleles contain trinucleotide repeats of 33 or more CAGs (usually without any CAA interruptions) (Pulst et al., 1996) . The repeat lengths for patient H266 were determined to be 22 and 44 by fragment length analysis (data not shown) and confirmed to be present also in iPSC line H266 c10 by sequencing both alleles individually (Fig. 1B) .
Furthermore, the expression of key pluripotency genes was observed both on RNA, as well as protein level, as demonstrated by qRTPCR analysis and immunocytochemistry, respectively ( Fig. 1C and D) . Additionally, the cells had the capacity to form derivatives of all three germ layers upon embryoid body differentiation (Fig. 1E) . Taken together, this validates the true pluripotent potential of the generated iPCS line. 
Materials and methods

Reprogramming using episomal vectors
Fibroblasts were cultured in fibroblast medium, consisting of Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine and 1% penicillin and streptomycin (Pen/Strep). 1 × 10 5 fibroblasts were electroporated with a total of 1 μg of episomal plasmids containing hOCT4 with a short hairpin to TP53 (shP53; Addgene plasmids 27077 and 27076, respectively), hSOX2 and hKLF4 (Addgene plasmid 27078), and hL-MYC and hLIN28 (Addgene plasmid 27080), (Okita et al., 2011) , and cultured in fibroblast medium. Electroporation was carried out using a Neon™ electroporation device with two pulses at 1200 V for 20 ms (Life Technologies). One week after electroporation, fibroblasts were trypsinized and split 1:2 onto matrigel-coated dishes (BD Biosciences) and cultured in E8 medium (Gibco) under hypoxic conditions. After four weeks, primary iPSC colonies were picked to establish stable clones.
Integration of episomal vectors
DNA for integration analysis was purified from fibroblasts and iPSCs using the DNeasy Blood and Tissue kit (Qiagen). Data was plotted using the delta delta Ct algorithm, 2 (−ΔΔCt) with fibroblasts and GAPDH as references. The following primers were used:
Sequencing Sanger sequencing of a 300 base pair region around the CAG repeat region of the ATXN2 gene was carried out in an ABI PRISM 310 Genetic Analyzer using the primers SCA2 seq2 forward 5′-CTTGGTCTCGGCGG GC-3′ and SCA2 seq2 reverse 5′-GAGGAGACCGAGGACGAGG-3′.
RNA extraction, cDNA synthesis, and quantitative real-time PCR (qRT-PCR) RNA was extracted using RNeasy Mini (QIAGEN) and cDNA synthesis was performed using Revert Aid First Strand cDNA synthesis kit (Thermo Scientific) according to the manufacturers' protocols. qRT-PCR was carried out using LightCycler 480 SYBR Green I Master (Roche). Data was plotted using the delta delta Ct algorithm, 2 (−ΔΔCt) . The following primers were used:
Immunocytochemistry
Immunocytochemistry was performed as previously described (Marthaler et al., 2013) . The following primary antibodies were used: Anti-OCT4 (Santa Cruz, sc 8628); anti-NANOG (Peprotech, 500P236); anti-TRA1-60 (BioLegend, 330602); anti-SSEA4 (BioLegend, 330402); anti-TUBB3 (Millipore, MAB1637); anti-SMA (Dako, M0851), anti-AFP (Dako, A0008); all 1:500. Secondary antibodies used were: Alexa Fluor 594 rabbit anti-goat (A21223) and goat anti-rabbit (A11072), Alexa Fluor 488 donkey anti-rabbit (A21206), donkey anti-goat (A11055), and goat anti-mouse (A11017), all 1:2000, (Invitrogen).
Embryoid body differentiation
iPSCs growing in E8 medium (Gibco) on matrigel (Corning Bioscience) were dissociated with EDTA (Gibco) and allowed to form aggregates in none-coated cell culture dishes. On day 3, aggregates were transferred to matrigel-coated dishes and medium was switched to differentiation medium: DMEM/F12 containing 20% FBS, L-glutamine, and non-essential amino acids (all Gibco) for meso-and endoderm induction, or DMEM/F12 containing 50% neurobasal medium, B27, N2, and L-glutamine (all Gibco) for ectoderm induction. Cells were fixed for immunocytochemistry on day 14.
Verification and authentication
An intact genome with no detectable abnormalities was demonstrated by karyotyping using G-banding (Fig. 1F) . Analysis was performed by Cell Guidance Systems, Cambridge, UK.
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